Company intelligence / Profile preview

Axis Biotec

Rio de Janeiro, Rio de Janeiro, Brazilprnewswire.com ↗

Ownership: Private
Development stage: Other

Overview

Axis Biotec is a leading Brazilian biotech holding company focused on research, development, and manufacturing of biologic drugs. It owns several subsidiaries active in pharmaceuticals, stem cell banking, plant-based biologics R&D, and regenerative medicine. The company's Rio de Janeiro facility holds ANVISA GMP certification for the manufacture of biologic drugs. Specific clinical results are not publicly detailed.

Modalities: BiologicCell therapy (via stem cell banking and regenerative medicine subsidiaries)Plant-based biologics (via vegetal expression subsidiary)
Industry: Biotech

Partnerships

Known to have partnerships with originators of biologic drugs for technology transfer projects since at least 2013

Beyond the preview

Go deeper on Axis Biotec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axis Biotec.

Explore the full profile